Filter
708
Text search:
meta-analysis
Featured
Recommendations
69
New Publications
84
Language
Document type
No document type
312
Studies & Reports
163
Guidelines
146
Manuals
26
Fact sheets
26
Strategic & Response Plan
19
Training Material
7
Resource Platforms
4
Situation Updates
3
Brochures
1
Infographics
1
Countries / Regions
Global
33
India
19
Latin America and the Carribbean
18
Western and Central Europe
15
Russia
14
Brazil
12
Africa
12
Malawi
10
Ukraine
9
South Africa
8
Uganda
7
Syria
6
Kenya
6
Tanzania
6
Middle East and North Africa
6
Philippines
5
Eastern Europe
5
Yemen
4
West and Central Africa
4
Asia
4
Sierra Leone
3
Senegal
3
Congo, Democratic Republic of
3
USA
3
Ethiopia
3
Cameroon
3
Germany
3
Rwanda
3
Mozambique
3
Namibia
3
East and Southern Africa
3
South–East Asia Region
3
Burkina Faso
2
Nigeria
2
Ghana
2
Zimbabwe
2
Haiti
2
South Sudan
2
Indonesia
2
Bangladesh
2
Myanmar / Burma
2
Chile
2
Paraguay
2
Mali
1
Guinea-Bissau
1
Niger
1
Nepal
1
Zambia
1
Sudan
1
Argentina
1
Peru
1
Colombia
1
Ecuador
1
Botswana
1
Angola
1
Sri Lanka
1
Western Pacific Region
1
Other region
1
Laos
1
Tajikistan
1
Moldova
1
Iran
1
Kyrgyzstan
1
Kazakhstan
1
Vietnam
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
141
Clinical Guidelines
88
Public Health
46
Women & Child Health
44
Key Resources
18
Pharmacy & Technologies
4
Capacity Building
3
Toolboxes
Mental Health
114
COVID-19
102
HIV
100
TB
69
NCDs
43
Planetary Health
29
NTDs
29
Disability
20
AMR
18
Caregiver
17
Refugee
10
Pharmacy
7
Polio
5
Ebola & Marburg
4
Conflict
4
Global Health Education
4
Malaria
4
Natural Hazards
3
Rapid Response
3
Zika
3
2.0 Rapid Response
3
Cholera
2
Specific Hazards
1
Social Ethics
1
The Lancet Regional Health - Americas 2024;30: 100681
Published Online 3 February 2024 https://doi.org/10.1016/j.lana.2024.100681
Asthma is one of the neglected diseases in Africa with a high prevalence. Allergic fungal diseases have been reported to complicate asthma progression and treatment outcomes. However, data about fungal asthma and its associated complications are limited in Africa. We aimed to estimate the burden of
...
Kassa BMC Infectious Diseases (2018) 18:216 https://doi.org/10.1186/s12879-018-3126-5
MICROBIAL DRUG RESISTANCEVolume 24, Number 5, 2018ªMary Ann Liebert, Inc.DOI: 10.1089/mdr.2017.0383
Antibiotic resistance (ABR) is a worldwide publichealth concern, with serious health, economic, and so-cietal repercussions. Its emergence is attributed to the se-lective pressure exerted by antib
...
Int J Environ Res Public Health. 2018 Jun; 15(6): 1279.
Published online 2018 Jun 16. doi: 10.3390/ijerph15061279
Afr J Psychiatry 2011;14:200-207
Schizophr Bull. 2014 Jan;40(1):192-213. doi: 10.1093/schbul/sbs150. Epub 2012 Dec 17.
Research
BMJ 2014;349:g4643 doi: 10.1136/bmj.g4643 (Published 5 August 2014), 1-11
Contemporary data for causes of vision impairment and blindness form an important basis of recommendations in public health policies. Refreshment of the Global Vision Database with recently published data sources permitted modelling of cause of vision loss data from 1990 to 2015, further disaggregat
...
PLOS ONE | DOI:10.1371/journal.pone.0142290 November 9, 2015; 1 / 16
Lancet Planet Health 2017 Published Online November 6, 2017 http://dx.doi.org/10.1016/S2542-5196(17)30141-9
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform
...
Resumo: o que é esta orientação dinâmica?
Pergunta clínica: qual é o papel dos medicamentos na prevenção da COVID-19?
Público-alvo: o público-alvo são os médicos e os tomadores de decisão na área da saúde.
Prática atual: o uso atual de medicamentos para prevenção da COVID-19 é
...